1
|
The Retinoschisis Consortium: Functional
implications of the spectrum of mutations found in 234 cases with
X-linked juvenile retinoschisis. Hum Mol Genet. 7:1185–1192. 1998.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Sauer CG, Gehrig A, Warneke-Wittstock R,
Marquardt A, Ewing CC, Gibson A, Lorenz B, Jurklies B and Weber BH:
Positional cloning of the gene associated with X-linked juvenile
retinoschisis. Nat Genet. 17:164–170. 1997. View Article : Google Scholar : PubMed/NCBI
|
3
|
Mooy CM, Van Den Born LI, Baarsma S,
Paridaens DA, Kraaijenbrink T, Bergen A and Weber BH: Hereditary
X-linked juvenile retinoschisis: A review of the role of Müller
cells. Arch Ophthalmol. 120:979–984. 2002.PubMed/NCBI
|
4
|
Molday RS, Kellner U and Weber BH:
X-linked juvenile retinoschisis: Clinical diagnosis, genetic
analysis, and molecular mechanisms. Prog Retin Eye Res. 31:195–212.
2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Tantri A, Vrabec TR, Cu-Unjieng A, Frost
A, Annesley WH Jr and Donoso LA: X-linked retinoschisis: A clinical
and molecular genetic review. Surv Ophthalmol. 49:214–230. 2004.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Sikkink SK, Biswas S, Parry NRA, Stanga PE
and Trump D: X-linked retinoschisis: An update. J Med Genet.
44:225–232. 2007. View Article : Google Scholar : PubMed/NCBI
|
7
|
Renner AB, Kellner U, Fiebig B, Cropp E,
Foerster MH and Weber BH: ERG variability in X-linked congenital
retinoschisis patients with mutations in the RS1 gene and the
diagnostic importance of fundus autofluorescence and OCT. Doc
Ophthalmol. 116:97–109. 2008. View Article : Google Scholar : PubMed/NCBI
|
8
|
Yu J, Ni Y, Keane PA, Jiang C, Wang W and
Xu G: Foveomacular schisis in juvenile X-linked retinoschisis: An
optical coherence tomography study. Am J Ophthalmol.
149:973–978.e2. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wang T, Waters CT, Rothman AMK, Jakins TJ,
Römisch K and Trump D: Intracellular retention of mutant
retinoschisin is the pathological mechanism underlying X-linked
retinoschisis. Hum Mol Genet. 11:3097–3105. 2002. View Article : Google Scholar : PubMed/NCBI
|
10
|
Wu WW, Wong JP, Kast J and Molday RS: RS1,
a discoidin domain-containing retinal cell adhesion protein
associated with X-linked retinoschisis, exists as a novel
disulfide-linked octamer. J Biol Chem. 280:10721–10730. 2005.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Molday LL, Hicks D, Sauer CG, Weber BHF
and Molday RS: Expression of X-linked retinoschisis protein RS1 in
photoreceptor and bipolar cells. Invest Ophthalmol Vis Sci.
42:816–825. 2001.PubMed/NCBI
|
12
|
Tolun G, Vijayasarathy C, Huang R, Zeng Y,
Li Y, Steven AC, Sieving PA and Heymann JB: Paired octamer rings of
retinoschisin suggest a junctional model for cell-cell adhesion in
the retina. Proc Natl Acad Sci USA. 113:5287–5292. 2016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Yzer S, Barbazetto I, Allikmets R, van
Schooneveld MJ, Bergen A, Tsang SH, Jacobson SG and Yannuzzi LA:
Expanded clinical spectrum of enhanced S-cone syndrome. JAMA
Ophthalmol. 131:1324–1330. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Sohn EH, Chen FK, Rubin GS, Moore AT,
Webster AR and MacLaren RE: Macular function assessed by
microperimetry in patients with enhanced S-cone syndrome.
Ophthalmology. 117:1199–1206.e1. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Bušić M, Bjeloš M, Bosnar D, Ramić S and
Bušić I: Cystoid macular lesions are resistant to topical
dorzolamide treatment in enhanced S-cone syndrome child. Doc
Ophthalmol. 132:67–73. 2016. View Article : Google Scholar : PubMed/NCBI
|
16
|
Salvatore S, Fishman GA and Genead MA:
Treatment of cystic macular lesions in hereditary retinal
dystrophies. Surv Ophthalmol. 58:560–584. 2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Sigler EJ: Microcysts in the inner nuclear
layer, a nonspecific SD-OCT sign of cystoid macular edema. Invest
Ophthalmol Vis Sci. 55:3282–3284. 2014. View Article : Google Scholar : PubMed/NCBI
|
18
|
Murata N, Togano T, Miyamoto D, Ochiai S
and Fukuchi T: Clinical evaluation of microcystic macular edema in
patients with glaucoma. Eye (Lond). 30:1502–1508. 2016. View Article : Google Scholar : PubMed/NCBI
|
19
|
Gregori NZ, Berrocal AM, Gregori G, Murray
TG, Knighton RW, Flynn HW Jr, Dubovy S, Puliafito CA and Rosenfeld
PJ: Macular spectral-domain optical coherence tomography in
patients with X linked retinoschisis. Br J Ophthalmol. 93:373–378.
2009. View Article : Google Scholar : PubMed/NCBI
|
20
|
Prenner JL, Capone A Jr, Ciaccia S, Takada
Y, Sieving PA and Trese MT: Congenital X-linked retinoschisis
classification system. Retina. 26 Suppl:S61–S64. 2006. View Article : Google Scholar : PubMed/NCBI
|
21
|
Gregori NZ, Lam BL, Gregori G, Ranganathan
S, Stone EM, Morante A, Abukhalil F and Aroucha PR: Wide-field
spectral-domain optical coherence tomography in patients and
carriers of X-linked retinoschisis. Ophthalmology. 120:169–174.
2013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Atchaneeyasakul LO, Trinavarat A,
Pituksung A, Jinda W, Thongnoppakhun W and Limwongse C: Mutations
in the XLRS1 gene in Thai families with X-linked juvenile
retinoschisis. Jpn J Ophthalmol. 54:89–93. 2010. View Article : Google Scholar : PubMed/NCBI
|
23
|
Li X, Ma X and Tao Y: Clinical features of
X linked juvenile retinoschisis in Chinese families associated with
novel mutations in the RS1 gene. Mol Vis. 13:804–812.
2007.PubMed/NCBI
|
24
|
Kim SY, Ko HS, Yu YS, Hwang JM, Lee JJ,
Kim SY, Kim JY, Seong MW, Park KH and Park SS: Molecular genetic
characteristics of X-linked retinoschisis in Koreans. Mol Vis.
15:833–843. 2009.PubMed/NCBI
|
25
|
Lesch B, Szabó V, Kánya M, Somfai GM,
Vámos R, Varsányi B, Pámer Z, Knézy K, Salacz G, Janáky M, et al:
Clinical and genetic findings in Hungarian patients with X-linked
juvenile retinoschisis. Mol Vis. 14:2321–2332. 2008.PubMed/NCBI
|
26
|
Riveiro-Alvarez R, Trujillo-Tiebas MJ,
Gimenez-Pardo A, Garcia-Hoyos M, Lopez-Martinez MA, Aguirre-Lamban
J, Garcia-Sandoval B, Vazquez-Fernandez del Pozo S, Cantalapiedra
D, Avila-Fernandez A, et al: Correlation of genetic and clinical
findings in Spanish patients with X-linked juvenile retinoschisis.
Invest Ophthalmol Vis Sci. 50:4342–4350. 2009. View Article : Google Scholar : PubMed/NCBI
|
27
|
Eksandh LC, Ponjavic V, Ayyagari R,
Bingham EL, Hiriyanna KT, Andréasson S, Ehinger B and Sieving PA:
Phenotypic expression of juvenile X-linked retinoschisis in Swedish
families with different mutations in the XLRS1 gene. Arch
Ophthalmol. 118:1098–1104. 2000. View Article : Google Scholar : PubMed/NCBI
|
28
|
Iannaccone A, Mura M, Dyka FM, Ciccarelli
ML, Yashar BM, Ayyagari R, Jablonski MM and Molday RS: An unusual
X-linked retinoschisis phenotype and biochemical characterization
of the W112C RS1 mutation. Vision Res. 46:3845–3852. 2006.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Verbakel SK, van de Ven JP, Le Blanc LMP,
Groenewoud JMM, de Jong EK, Klevering BJ and Hoyng CB: Carbonic
anhydrase inhibitors for the treatment of cystic macular lesions in
children with X-linked juvenile retinoschisis. Invest Ophthalmol
Vis Sci. 57:5143–5147. 2016. View Article : Google Scholar : PubMed/NCBI
|
30
|
Marangoni D, Bush RA, Zeng Y, Wei LL,
Ziccardi L, Vijayasarathy C, Bartoe JT, Palyada K, Santos M,
Hiriyanna S, et al: Ocular and systemic safety of a recombinant
AAV8 vector for X-linked retinoschisis gene therapy: GLP studies in
rabbits and Rs1-KO mice. Mol Ther Methods Clin Dev. 5:160112016.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Zeng Y, Petralia RS, Vijayasarathy C, Wu
Z, Hiriyanna S, Song H, Wang YX, Sieving PA and Bush RA: Retinal
structure and gene therapy outcome in retinoschisin-deficient mice
assessed by spectral-domain optical coherence tomography. Invest
Ophthalmol Vis Sci. 57:OCT277–OCT287. 2016. View Article : Google Scholar : PubMed/NCBI
|
32
|
Bashar AE, Metcalfe AL, Viringipurampeer
IA, Yanai A, Gregory-Evans CY and Gregory-Evans K: An ex vivo gene
therapy approach in X-linked retinoschisis. Mol Vis. 22:718–733.
2016.PubMed/NCBI
|
33
|
Apaolaza PS, Del Pozo-Rodríguez A, Solinís
MA, Rodríguez JM, Friedrich U, Torrecilla J, Weber BH and
Rodríguez-Gascón A: Structural recovery of the retina in a
retinoschisin-deficient mouse after gene replacement therapy by
solid lipid nanoparticles. Biomaterials. 90:40–49. 2016. View Article : Google Scholar : PubMed/NCBI
|
34
|
Study of RS1 ocular gene transfer for
X-linked retinoschisis. https://www.clinicaltrials.govDecember. 2016
|
35
|
Safety and efficacy of rAAV-hRS1 in
patients with X-linked retinoschisis (XLRS). https://www.clinicaltrials.govDecember. 2016
|